Cargando…

A case of trazodone induced prolonged hypogeusia

INTRODUCTION: Plenty of antidepressants have been reported to induce unpleasant tastes and/or odors as well as altered chemosensations when administered alone or in combination with other medications. Trazodone induced hypogeusia (decreased taste sensation) is a rare side effect. In this report, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Tekdemir, R., Kandeğer, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566953/
http://dx.doi.org/10.1192/j.eurpsy.2022.1856
_version_ 1784809280074940416
author Tekdemir, R.
Kandeğer, A.
author_facet Tekdemir, R.
Kandeğer, A.
author_sort Tekdemir, R.
collection PubMed
description INTRODUCTION: Plenty of antidepressants have been reported to induce unpleasant tastes and/or odors as well as altered chemosensations when administered alone or in combination with other medications. Trazodone induced hypogeusia (decreased taste sensation) is a rare side effect. In this report, we would like to present a male patient with with hypogeusia after trazodona use and persisting for 3 months after the drug was discontinued will be discussed. OBJECTIVES: A 52-year-old male, Trazodone 50 mg/day was started 4 months ago due to difficulty in falling asleep. On the 25th day of her daily treatment, her sense of taste began to decrease and gradually became more severe. So he stopped his treatment and he applied to the internal medicine and neurology polyclinics. Routine blood tests were within normal limits. To rule out the possibility of covid 19, 2 pcr tests were done and it was found negative. No recommendations other than chewing gum. The patient applied to the psychiatry polyclinic with the complaint of decreased taste sensation that in the 3rd month of his complaints. METHODS: CASE REPORT RESULTS: CASE REPORT CONCLUSIONS: Chemosensory side effects due to drugs are frequently seen in the elderly and in polypharmacy. It is usually accompanied by a decrease in salivary secretion. It resolves shortly after the causative drug(s) are stopped. It is important that our patient is middle-aged, does not have additional medical diseases and does not use drugs, and his complaints continue for 3 months after the stopped of Trazodone. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9566953
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95669532022-10-17 A case of trazodone induced prolonged hypogeusia Tekdemir, R. Kandeğer, A. Eur Psychiatry Abstract INTRODUCTION: Plenty of antidepressants have been reported to induce unpleasant tastes and/or odors as well as altered chemosensations when administered alone or in combination with other medications. Trazodone induced hypogeusia (decreased taste sensation) is a rare side effect. In this report, we would like to present a male patient with with hypogeusia after trazodona use and persisting for 3 months after the drug was discontinued will be discussed. OBJECTIVES: A 52-year-old male, Trazodone 50 mg/day was started 4 months ago due to difficulty in falling asleep. On the 25th day of her daily treatment, her sense of taste began to decrease and gradually became more severe. So he stopped his treatment and he applied to the internal medicine and neurology polyclinics. Routine blood tests were within normal limits. To rule out the possibility of covid 19, 2 pcr tests were done and it was found negative. No recommendations other than chewing gum. The patient applied to the psychiatry polyclinic with the complaint of decreased taste sensation that in the 3rd month of his complaints. METHODS: CASE REPORT RESULTS: CASE REPORT CONCLUSIONS: Chemosensory side effects due to drugs are frequently seen in the elderly and in polypharmacy. It is usually accompanied by a decrease in salivary secretion. It resolves shortly after the causative drug(s) are stopped. It is important that our patient is middle-aged, does not have additional medical diseases and does not use drugs, and his complaints continue for 3 months after the stopped of Trazodone. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9566953/ http://dx.doi.org/10.1192/j.eurpsy.2022.1856 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Tekdemir, R.
Kandeğer, A.
A case of trazodone induced prolonged hypogeusia
title A case of trazodone induced prolonged hypogeusia
title_full A case of trazodone induced prolonged hypogeusia
title_fullStr A case of trazodone induced prolonged hypogeusia
title_full_unstemmed A case of trazodone induced prolonged hypogeusia
title_short A case of trazodone induced prolonged hypogeusia
title_sort case of trazodone induced prolonged hypogeusia
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566953/
http://dx.doi.org/10.1192/j.eurpsy.2022.1856
work_keys_str_mv AT tekdemirr acaseoftrazodoneinducedprolongedhypogeusia
AT kandegera acaseoftrazodoneinducedprolongedhypogeusia
AT tekdemirr caseoftrazodoneinducedprolongedhypogeusia
AT kandegera caseoftrazodoneinducedprolongedhypogeusia